150 related articles for article (PubMed ID: 27585657)
21. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
22. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
23. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.
Wang X; Dai J
Stem Cells; 2010 May; 28(5):885-93. PubMed ID: 20333750
[TBL] [Abstract][Full Text] [Related]
24. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
25. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.
Atlasi Y; Mowla SJ; Ziaee SA; Gokhale PJ; Andrews PW
Stem Cells; 2008 Dec; 26(12):3068-74. PubMed ID: 18787205
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
27. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
28. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
30. The differential expression of OCT4 isoforms in cervical carcinoma.
Li SW; Wu XL; Dong CL; Xie XY; Wu JF; Zhang X
PLoS One; 2015; 10(3):e0118033. PubMed ID: 25816351
[TBL] [Abstract][Full Text] [Related]
31. A novel variant of Oct3/4 gene in mouse embryonic stem cells.
Guo CL; Liu L; Jia YD; Zhao XY; Zhou Q; Wang L
Stem Cell Res; 2012 Sep; 9(2):69-76. PubMed ID: 22683460
[TBL] [Abstract][Full Text] [Related]
32. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
33. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
34. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
Poursani EM; Mohammad Soltani B; Mowla SJ
Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
[TBL] [Abstract][Full Text] [Related]
35. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
36. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
37. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.
Karoubi G; Cortes-Dericks L; Gugger M; Galetta D; Spaggiari L; Schmid RA
J Surg Oncol; 2010 Nov; 102(6):689-98. PubMed ID: 20721963
[TBL] [Abstract][Full Text] [Related]
38. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
39. OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to οxaliplatin in colon cancer.
Wen KM; Zhang GH; Li J; Chen ZQ; Cheng YL; Su X; Zeng QL
Oncol Rep; 2015 Dec; 34(6):2943-52. PubMed ID: 26398480
[TBL] [Abstract][Full Text] [Related]
40. Alternative Splicing Generates Different 5' UTRs in OCT4B Variants.
Poursani EM; Mehravar M; Shahryari A; Mowla SJ; Mohammad Soltani B
Avicenna J Med Biotechnol; 2017; 9(4):201-204. PubMed ID: 29090070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]